scholarly journals Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer

Neoplasia ◽  
2020 ◽  
Vol 22 (2) ◽  
pp. 120-128 ◽  
Author(s):  
Alexandra M. Kane ◽  
Lochlan J. Fennell ◽  
Cheng Liu ◽  
Jennifer Borowsky ◽  
Diane M. McKeone ◽  
...  
2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Camille Ternet ◽  
Christina Kiel

AbstractThe intestinal epithelium acts as a physical barrier that separates the intestinal microbiota from the host and is critical for preserving intestinal homeostasis. The barrier is formed by tightly linked intestinal epithelial cells (IECs) (i.e. enterocytes, goblet cells, neuroendocrine cells, tuft cells, Paneth cells, and M cells), which constantly self-renew and shed. IECs also communicate with microbiota, coordinate innate and adaptive effector cell functions. In this review, we summarize the signaling pathways contributing to intestinal cell fates and homeostasis functions. We focus especially on intestinal stem cell proliferation, cell junction formation, remodelling, hypoxia, the impact of intestinal microbiota, the immune system, inflammation, and metabolism. Recognizing the critical role of KRAS mutants in colorectal cancer, we highlight the connections of KRAS signaling pathways in coordinating these functions. Furthermore, we review the impact of KRAS colorectal cancer mutants on pathway rewiring associated with disruption and dysfunction of the normal intestinal homeostasis. Given that KRAS is still considered undruggable and the development of treatments that directly target KRAS are unlikely, we discuss the suitability of targeting pathways downstream of KRAS as well as alterations of cell extrinsic/microenvironmental factors as possible targets for modulating signaling pathways in colorectal cancer.


2021 ◽  
pp. 1-10
Author(s):  
Suzanne Mashtoub ◽  
Lauren C. Chartier ◽  
Debbie Trinder ◽  
Ian C. Lawrance ◽  
Gordon S. Howarth

Cells ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. 39
Author(s):  
Crescenzo Massaro ◽  
Elham Safadeh ◽  
Giulia Sgueglia ◽  
Hendrik G. Stunnenberg ◽  
Lucia Altucci ◽  
...  

Despite substantial progress in cancer therapy, colorectal cancer (CRC) is still the third leading cause of cancer death worldwide, mainly due to the acquisition of resistance and disease recurrence in patients. Growing evidence indicates that deregulation of hormone signaling pathways and their cross-talk with other signaling cascades inside CRC cells may have an impact on therapy resistance. MicroRNAs (miRNAs) are small conserved non-coding RNAs thatfunction as negative regulators in many gene expression processes. Key studies have identified miRNA alterations in cancer progression and drug resistance. In this review, we provide a comprehensive overview and assessment of miRNAs role in hormone signaling pathways in CRC drug resistance and their potential as future targets for overcoming resistance to treatment.


2008 ◽  
Vol 134 (4) ◽  
pp. A-305-A-306
Author(s):  
Kenneth Hung ◽  
Larissa Georgeon Richard ◽  
Alexandra Kunin ◽  
Umar Mahmood ◽  
Raju Kucherlapati

2014 ◽  
Vol 50 ◽  
pp. S136
Author(s):  
V. Meniel ◽  
I. Martin-Berenjeno ◽  
B. Vanhaesebroeck ◽  
A.R. Clarke

2015 ◽  
Vol 1627 ◽  
pp. 233-242 ◽  
Author(s):  
Yujeong Lee ◽  
Hye Jeong Chun ◽  
Kyung Moon Lee ◽  
Young-Suk Jung ◽  
Jaewon Lee

Sign in / Sign up

Export Citation Format

Share Document